Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Paraganglioma × Biopsy × Clear all

Sponsor

Conditions

Breast Neoplasms 16 Lymphoma 12 Neoplasm Metastasis 9 Multiple Myeloma 9 Leukemia, Myeloid, Acute 8 Lung Neoplasms 7 Melanoma 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Lymphoma, Non-Hodgkin 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Carcinoma, Non-Small-Cell Lung 5 Neuroblastoma 4 Lymphoma, Follicular 4 Burkitt Lymphoma 4 Sarcoma, Kaposi 3 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myeloproliferative Disorders 3 Myelodysplastic Syndromes 3 Malignant Solid Neoplasm 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myelomonocytic, Acute 3 Leukemia 3 Hematologic Neoplasms 3 Head and Neck Neoplasms 3 HIV Infections 3 Fallopian Tube Neoplasms 3 Adenocarcinoma Of Esophagus 3 Wilms Tumor 2

Interventions

3-Iodobenzylguanidine 3 pazopanib 1 lutetium Lu 177 dotatate 1 guadecitabine 1 gallium Ga 68 dotatate 1 copper dotatate CU-64 1 cabozantinib 1 atezolizumab 1 Radiosurgery 1 Phenoxybenzamine 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Lutetium-177 1 Lutetium 1 Iodine-131 1 Doxazosin 1 Axitinib 1 3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡